PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
PharmEnable has raised €9.0M across 2 funding rounds from 9 investors, most recently a Seed round in May 2023. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-05-22 | Seed | €6.9M | Arrowfield Capital,Cambridge Enterprise,Heyford Trust,Jonathan Milner,Martlet Capital,MP Healthcare Venture Management+2 more | View deal → |
| 2020-01-07 | Seed | €2.1M | Cambridge Enterprise,University of Cambridge Enterprise | View deal → |
